Stem Cell Blog

Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.



hurler-syndrome-1080x650-1.png

Have you heard of Hurler Syndrome? If not, you’re most likely in the majority.

It is rare indeed. Obscure, even. Perhaps Hurler Syndrome wouldn’t be on your radar unless it had touched you, or the family of someone you know. It’s estimated that just one in every 100,000 births will be affected by this condition (https://www.ncbi.nlm.nih.gov/books/NBK532261/), yet it devastates lives.


autism-clinical-trial-blog.png

A new phase II clinical trial has indicated that umbilical cord blood infusions are safe and are associated with improved social and communication abilities in children with autism.

Results from the study show that umbilical cord blood infusion were safe and well tolerated by the 180 children participating in the clinical trial. Cord blood was also associated with improvements in communication skills in children with autism spectrum disorder (ASD) without intellectual disability (ID).


MSC-covid-treatment.png

Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19.

As the pandemic continues, the race is truly on to find an effective treatment for COVID-19. With more than 500 clinical trials currently underway across the world, researchers are channelling all of their efforts and expertise in the hope of finding a cure.